Radiopharmaceuticals and Tracers

This channel includes news and new technology innovations for nuclear and molecular imaging agents, radiotracers and radiopharmaceuticals used inPETorSPECT成像。这包括心肌灌注制剂的进展。

NorthStar will provide Clovis with its environmentally preferred, high purity non-carrier-added (n.c.a.) Ac-225
News|Radiopharmaceuticals and Tracers

July 20, 2022 — -NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

TimeJuly 20, 2022
arrow
SNMMI Elects Cathy Sue Cutler, PhD, FSNMMI, as Vice President-Elect at 2022 Annual Meeting
News|SNMMI

June 16, 2022 — Cathy Sue Cutler, PhD, FSNMMI, director of the medical isotope research and production program at ...

TimeJune 16, 2022
arrow
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) announced the creation of the Mars Shot Fund, an initiative to raise $100 million to help pay for research into nuclear medicine, molecular imaging, and therapy.
News|SNMMI

June 14, 2022 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) announced the creation of the Mars Shot ...

TimeJune 14, 2022
arrow
SNMMI Elects Munir Ghesani, MD, FACNM, FACR, as President at 2022 Annual Meeting
News|SNMMI

2022年6月14日- Munir Ghesani,医学博士,FACNM, FACR,西奈山健康中心核医学和分子成像主管…

TimeJune 14, 2022
arrow
SpectronRx, a leading contract development and manufacturing organization (CDMO) for the life sciences industry that specializes in radiopharmaceuticals, today announced that it will showcase its new Actinium-225 production facility during this year’s annual Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting being held June 11-14 in Vancouver, British Columbia, Canada.
News|Radiopharmaceuticals and Tracers

June 13, 2022 — SpectronRx, a leading contract development and manufacturing organization (CDMO) for the life sciences ...

TimeJune 13, 2022
arrow
Curie Therapeutics will be provided with priority access to NorthStar’s high purity non-carrier added (n.c.a.) Ac-225, which will be used to advance its multimodal pipeline of precision radiopharmaceuticals to address broad unmet needs in treatment of patients with solid tumors
News|Radiopharmaceuticals and Tracers

June 8, 2022 — NorthStar Medical Radioisotopes, LLC (‘NorthStar’), a global innovator in the development, production and ...

TimeJune 08, 2022
arrow
预计到2030年,全球核医学市场规模将达到244亿美元,从2022年到2030年,CAGR将以13.0%的速度增长。
Feature|Nuclear Imaging

The "Nuclear Medicine Market Size, Share & Trends Analysis Report by Product (Diagnostics (SPECT, PET)), Therapeutics ...

TimeMay 26, 2022
arrow
Oral presentation based on Late-breaking Abstract featured at American Urological Association’s 2022 Annual Meeting (AUA2022)
News|Radiopharmaceuticals and Tracers

2022年5月16日- Blue Earth Diagnostics,一家布拉科公司,在研发和商业化方面被公认的领导者……

TimeMay 16, 2022
arrow
A schematic of the 99Mo/99mTc production system based on an electron linear accelerator and activated carbon-based 99mTc generator
News|Radiopharmaceuticals and Tracers

2022年4月22日——一种常用的放射性同位素,锝-99m,用于医疗诊断,经常遭受…

TimeApril 22, 2022
arrow
MARIA研究反应堆(波兰)增加了额外的运行天数,这有助于减少HFR生产能力的损失。
News|Nuclear Imaging

February 18, 2022 — The Nuclear Medicine Europe (NMEu) Emergency Response Team held a call on February 14 on the ...

TimeFebruary 18, 2022
arrow
MURR staff work to produce lutetium-177 (Lu-177). Image courtesy of the University of Missouri
News|Nuclear Imaging

February 11, 2022 — Due to a recent unexpected reactor shutdown in Europe, the University of Missouri Research Reactor ...

TimeFebruary 11, 2022
arrow
Videos|Radiopharmaceuticals and Tracers

Ana Kiess, M.D., Ph.D., assistant professor of radiation oncology and molecular radiation sciences, Johns Hopkins ...

TimeNovember 17, 2021
arrow
Bicameral legislation in U.S. House and Senate designed to address equity issues in patient access and affordability for innovative diagnostic radiopharmaceuticals
News|Radiopharmaceuticals and Tracers

2021年9月17日- Blue Earth Diagnostics,一家布拉科公司,在开发和…

TimeSeptember 17, 2021
arrow
NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic applications and medical imaging, and POINT Biopharma Global Inc. (NASDAQ: PNT), a company accelerating the discovery, development, and global access to life changing radiopharmaceuticals, today announced the signing of a supply agreement for the therapeutic medical radioisotope actinium-225 (Ac-225).
News|Radiopharmaceuticals and Tracers

September 10, 2021 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

TimeSeptember 10, 2021
arrow
GE Healthcare also recently announced Xeleris V, a new virtualized, flexible AI-powered solution that provides clinicians secure access to data from anywhere – helping them make personalized care decisions and treatment recommendations that are at the heart of precision health.
News|Nuclear Imaging

June 22, 2021 — At the Society of Nuclear Medicine and Molecular Imaging’s (SNMMI) 2021 summer conference, GE Healthcare ...

TimeJune 22, 2021
arrow
Master Supply Agreement encompasses clinical development and commercial supply for Clarity’s Cu-67-based candidates to treat neuroblastoma, breast and prostate cancers, among others
News|Radiopharmaceuticals and Tracers

June 22, 2021 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

TimeJune 22, 2021
arrow
Sponsored Content|Blog|Contrast Media Injectors

Technology advancements are changing consumers’ expectations, driving industries to adapt and evolve, and the healthcare ...

TimeApril 29, 2021
arrow
#NorthStar Medical #Radioisotopes, LLC, a global innovator in the development, production and commercialization of #radiopharmaceuticals used for #medicalimaging and #therapeutic applications, announced a corporate update highlighting progress across its key programs during the past twelve months and upcoming milestones.
News|Radiopharmaceuticals and Tracers

April 16, 2021 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

TimeApril 16, 2021
arrow
Shine executives are joined by the company’s construction managers and partners at its medical isotope production facility. The group was commemorating the facility’s achievement of weathertight status
News|Radiopharmaceuticals and Tracers

March 26, 2021 — Shine Medical Technologies LLC announced that construction of the exterior structure of its first-of-a ...

TimeMarch 26, 2021
arrow
Diagnostic imaging studies using Tc-99m inform healthcare decisions for approximately 30 million patients annually around the world
News|Nuclear Imaging

2021年3月8日消息——IBA (Ion Beam Applications s.a., EURONEXT)和NorthStar Medical radio同位素有限责任公司宣布…

TimeMarch 08, 2021
arrow
Subscribe Now